Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Clinical trial NCT02690558 · COMPLETED
Trial details
- NCT number
- NCT02690558
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-07-06
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.